320 likes | 463 Views
Dr Martyn Thomas Kings College Hospital BCIS President. DGH v Tertiary Intervention Is there really a conflict? “The BCIS Perspective”. MY CONFLICTS OF INTEREST ARE: Research Support: Boston Scientific, Cordis and Medtronic Advisory Board for: Boston, Cordis, Abbott, Lilly and Nycomed.
E N D
Dr Martyn Thomas Kings College Hospital BCIS President DGH v Tertiary InterventionIs there really a conflict?“The BCIS Perspective”
MY CONFLICTS OF INTEREST ARE: Research Support: Boston Scientific, Cordis and Medtronic Advisory Board for: Boston, Cordis, Abbott, Lilly and Nycomed.
DGH v Tertiary Intervention(p.s. surgical v non surgicalcentres!)Is there really a conflict?“The BCIS Perspective” • What “experience” do I have to give such a talk? - BCIS President - Currently perform PCI at Kings College Hospital (Teriary) AND the “Mayday Hospital” (DGH). Gives some perspective!!
DGH v Tertiary InterventionIs there really a conflict?“The BCIS Perspective” Where does the UK stand in worldwide terms with regard to revascularisation??
2005 data: Ludman Total UK PCI Procedures
2005 data: Ludman UK Centres - 2005
2005 data: Ludman Number of PCIs performed in 2005(per NHS Centre) Mean = 1028 Data from: all 65 NHS centres
2005 data: Ludman MACE (2005) - All PCIsAll Data from CCAD + Form C
2005 data: Ludman Surgical Cover(all 83 NHS and Private Centres)
Tertiary (Surgical) and DGH (Non-Surgical) centres receiving BCIS visits since 2004 (the “Truth!”. 1:20 is a Surgical centre!
Tertiary (surgical centre) ParanoiaWhere is all the work?What will we do?
The Model (DOH) • 3 levels of revascularisation tested; 1900, 2200 and 2500 per million, by 2015 • 7.2% increase in ICDs, reaching latest NICE guidelines by 2015. • A range of 5-15% increase in interventions for EP/arrythmias.
Potential growth areas? For the surgical centres • “Hole” closure: PFO, ASD etc. • Percutaneous Valve therapy. • Intramyocardial injection therapy • “Gene/cell” therapy.
Specific “issues” with a change toward PCI in non-surgical centres(not outcome related!) • Changes needed in the organisation of some interventional research. • Case Mix (the Tariff).
Interventional ResearchConsequences of a “devolved service” • Currently a “handful” of surgical centres have the infra-structure, and perform international multicentre randomised trials and registries. • For FIM type cases this requires relatively straightforward lesions………..these will be increasingly rare in the surgical centres. • A change of infra-structure/research staff etc will therefore be necessary for this activity to continue.
The TariffProblems of Case Mix • E15: Percutaneous coronary intervention • Elective £3660 • Non-elective £4758 • CABG elective £7195 • CABG non elective £8748 • Kings MFF 1.3 • +16% uplift • Leads to PCI elective=£5519 and PCI non elective=£7175
Tertiary centre: year 1100 cases referred from DGH60% unstable and 40% stable25% multiple stents • Simple elective: make £500, Complex elective: lose £1000 • Simple non-elective: make £1,500, Complex non-elective: lose 1,500 • Revenue: • Simple non-elective: +£67,500 • Complex non-elective: -£22,500 • Simple elective: +£15,000 • Complex elective: -£10,000 • Net income= +£50,000
Tertiary centre: year 225 cases referred from DGH(all complex), 75 cases done in non surgical centre. • Non-surgical centre: • Simple non-elective: +£67,500 • Simple complex: +£15,000 • Revenue: +£82,500 • Tertiary centre: • Complex non-elective: -£22,500 • Complex elective: -£10,000 • Revenue: -£32,500
Potential consequences of the Tariff and non-surgical centre PCI. • Potential diversion of revascularisation toward surgery because of “skewed” case mix leading to PCI being non-viable. • Potential of “profiteering” of DGH at the expense of Quality.
Personnel view!! • Fully supportive of non-surgical centre PCI, as long as volume and expertise are maintained. • Here are the last x2 cases at the Mayday………….last Thursday.
Conclusions • Training and experience has more influence on outcome of PCI than location. • As long as individual and institutional volumes are maintained BCIS fully supports the development of non-surgical centre PCI. • Strong links between the surgical centre and non-surgical centre with exchange of personnel and audit data in both directions is essential. • Achievement of “European” type rates of revascularisation cannot be done without full use of the non-surgical cath labs.
Conclusions • Development of research infrastructure within the non-surgical centres should be encouraged. • Surgical centre operators should be encouraged to “support” non-surgical centres, including performing PCI sessions. • Some form of tariff sharing may be required across Networks to make all units viable and to avoid distortion of clinical practice for financial reasons.